Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy.

Lenders M, Stappers F, Niemietz C, Schmitz B, Boutin M, Ballmaier PJ, Zibert A, Schmidt H, Brand SM, Auray-Blais C, Brand E.

J Med Genet. 2019 Aug;56(8):548-556. doi: 10.1136/jmedgenet-2019-106005. Epub 2019 Apr 22.

PMID:
31010832
2.

Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.

Polishchuk EV, Merolla A, Lichtmannegger J, Romano A, Indrieri A, Ilyechova EY, Concilli M, De Cegli R, Crispino R, Mariniello M, Petruzzelli R, Ranucci G, Iorio R, Pietrocola F, Einer C, Borchard S, Zibert A, Schmidt HH, Di Schiavi E, Puchkova LV, Franco B, Kroemer G, Zischka H, Polishchuk RS.

Gastroenterology. 2019 Mar;156(4):1173-1189.e5. doi: 10.1053/j.gastro.2018.11.032. Epub 2018 Nov 17.

PMID:
30452922
3.

Hepatocyte-like cells reveal novel role of SERPINA1 in transthyretin amyloidosis.

Niemietz C, Fleischhauer L, Sandfort V, Guttmann S, Zibert A, Schmidt HH.

J Cell Sci. 2018 Nov 26;131(23). pii: jcs219824. doi: 10.1242/jcs.219824.

4.

Functional Characterization of Novel ATP7B Variants for Diagnosis of Wilson Disease.

Guttmann S, Bernick F, Naorniakowska M, Michgehl U, Groba SR, Socha P, Zibert A, Schmidt HH.

Front Pediatr. 2018 Apr 30;6:106. doi: 10.3389/fped.2018.00106. eCollection 2018.

5.

Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells.

Guttmann S, Chandhok G, Groba SR, Niemietz C, Sauer V, Gomes A, Ciarimboli G, Karst U, Zibert A, Schmidt HH.

Oncotarget. 2017 Dec 12;9(1):743-754. doi: 10.18632/oncotarget.23142. eCollection 2018 Jan 2.

6.

Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.

Hachmöller O, Zibert A, Zischka H, Sperling M, Groba SR, Grünewald I, Wardelmann E, Schmidt HH, Karst U.

J Trace Elem Med Biol. 2017 Dec;44:26-31. doi: 10.1016/j.jtemb.2017.05.008. Epub 2017 May 29.

PMID:
28965585
7.

Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposure.

Groba SR, Guttmann S, Niemietz C, Bernick F, Sauer V, Hachmöller O, Karst U, Zischka H, Zibert A, Schmidt HH.

Metallomics. 2017 Sep 20;9(9):1279-1287. doi: 10.1039/c7mt00189d.

PMID:
28805879
8.

Thermal shift assay for evaluation of transthyretin stability in plasma.

Fleischhauer L, Niemietz C, Reinartz Groba S, Ballmaier P, Sauer V, Guttmann S, Zibert A, Schmidt H.

Amyloid. 2017 Mar;24(sup1):34-35. doi: 10.1080/13506129.2017.1281121. No abstract available.

PMID:
28434373
9.

FAP plasma-induced cellular toxicity.

Niemietz C, Chandhok G, Fleischhauer L, Ballmaier P, Sauer V, Guttmann S, Zibert A, Schmidt H.

Amyloid. 2017 Mar;24(sup1):87-88. doi: 10.1080/13506129.2017.1278692. No abstract available.

PMID:
28434333
10.

De novo hereditary (familial) amyloid polyneuropathy (FAP) in a FAP liver recipient.

Guttmann S, Röcken C, Schmidt M, Grünewald I, Zibert A, Stypmann J, Schilling M, Schmidt H.

Amyloid. 2017 Mar;24(sup1):126-127. doi: 10.1080/13506129.2017.1293642. No abstract available.

PMID:
28434329
11.

In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.

Hoepfner J, Kleinsorge M, Papp O, Alfken S, Heiringhoff R, Pich A, Sauer V, Zibert A, Göhring G, Schmidt H, Sgodda M, Cantz T.

Biol Chem. 2017 Jul 26;398(8):939-954. doi: 10.1515/hsz-2016-0258.

PMID:
28051995
12.

Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells.

Niemietz CJ, Sauer V, Stella J, Fleischhauer L, Chandhok G, Guttmann S, Avsar Y, Guo S, Ackermann EJ, Gollob J, Monia BP, Zibert A, Schmidt HH.

PLoS One. 2016 Sep 1;11(9):e0161455. doi: 10.1371/journal.pone.0161455. eCollection 2016.

13.

Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.

Chandhok G, Horvath J, Aggarwal A, Bhatt M, Zibert A, Schmidt HH.

World J Gastroenterol. 2016 Apr 28;22(16):4109-19. doi: 10.3748/wjg.v22.i16.4109.

14.

Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin.

Spincemaille P, Chandhok G, Zibert A, Schmidt H, Verbeek J, Chaltin P, Cammue BP, Cassiman D, Thevissen K.

Microb Cell. 2014 Oct 24;1(11):352-364. doi: 10.15698/mic2014.11.175.

15.

The plant decapeptide OSIP108 prevents copper-induced toxicity in various models for Wilson disease.

Spincemaille P, Pham DH, Chandhok G, Verbeek J, Zibert A, Libbrecht L, Schmidt H, Esguerra CV, de Witte PA, Cammue BP, Cassiman D, Thevissen K.

Toxicol Appl Pharmacol. 2014 Oct 15;280(2):345-51. doi: 10.1016/j.taap.2014.08.005. Epub 2014 Aug 16.

PMID:
25134866
16.

The plant decapeptide OSIP108 prevents copper-induced apoptosis in yeast and human cells.

Spincemaille P, Chandhok G, Newcomb B, Verbeek J, Vriens K, Zibert A, Schmidt H, Hannun YA, van Pelt J, Cassiman D, Cammue BPA, Thevissen K.

Biochim Biophys Acta. 2014 Jun;1843(6):1207-1215. doi: 10.1016/j.bbamcr.2014.03.004. Epub 2014 Mar 13.

17.

Wilson disease mutation pattern with genotype-phenotype correlations from Western India: confirmation of p.C271* as a common Indian mutation and identification of 14 novel mutations.

Aggarwal A, Chandhok G, Todorov T, Parekh S, Tilve S, Zibert A, Bhatt M, Schmidt HH.

Ann Hum Genet. 2013 Jul;77(4):299-307. doi: 10.1111/ahg.12024. Epub 2013 Apr 2.

18.

Gender and strain-specific differences in the development of steatosis in rats.

Stöppeler S, Palmes D, Fehr M, Hölzen JP, Zibert A, Siaj R, Schmidt HH, Spiegel HU, Bahde R.

Lab Anim. 2013 Jan;47(1):43-52. doi: 10.1177/0023677212473717.

PMID:
23467489
19.

Longitudinal analysis of serum miR-122 in a rat model of Wilson's disease.

Siaj R, Sauer V, Stöppeler S, Gerß J, Spiegel HU, Köhler G, Zibert A, Schmidt HH.

Hepatol Int. 2012 Oct;6(4):770-7. doi: 10.1007/s12072-012-9348-5. Epub 2012 Feb 11.

20.

Dietary copper triggers onset of fulminant hepatitis in the Long-Evans cinnamon rat model.

Siaj R, Sauer V, Stöppeler S, Spiegel HU, Köhler G, Zibert A, Schmidt HH.

World J Gastroenterol. 2012 Oct 21;18(39):5542-50. doi: 10.3748/wjg.v18.i39.5542.

21.

Repeated transplantation of hepatocytes prevents fulminant hepatitis in a rat model of Wilson's disease.

Sauer V, Siaj R, Stöppeler S, Bahde R, Spiegel HU, Köhler G, Zibert A, Schmidt HH.

Liver Transpl. 2012 Feb;18(2):248-59. doi: 10.1002/lt.22466.

22.

Role of angiotensin-1 receptor blockade in cirrhotic liver resection.

Bahde R, Kebschull L, Stöppeler S, Zibert A, Siaj R, Hölzen JP, Minin E, Schmidt HH, Spiegel HU, Palmes D.

Liver Int. 2011 May;31(5):642-55. doi: 10.1111/j.1478-3231.2011.02493.x. Epub 2011 Mar 9.

PMID:
21457437
23.

Overexpressed ATP7B protects mesenchymal stem cells from toxic copper.

Sauer V, Siaj R, Todorov T, Zibert A, Schmidt HH.

Biochem Biophys Res Commun. 2010 May 7;395(3):307-11. doi: 10.1016/j.bbrc.2010.03.158. Epub 2010 Apr 1.

PMID:
20362556
24.

Laser secondary neutral mass spectrometry for copper detection in micro-scale biopsies.

Kriegeskotte C, Cantz T, Haberland J, Zibert A, Haier J, Köhler G, Schöler HR, Schmidt HH, Arlinghaus HF.

J Mass Spectrom. 2009 Oct;44(10):1417-22. doi: 10.1002/jms.1634.

PMID:
19753579
25.

The CD70/CD27 pathway is critical for stimulation of an effective cytotoxic T cell response against B cell precursor acute lymphoblastic leukemia.

Glouchkova L, Ackermann B, Zibert A, Meisel R, Siepermann M, Janka-Schaub GE, Goebel U, Troeger A, Dilloo D.

J Immunol. 2009 Jan 1;182(1):718-25.

26.

Impact of rapamycin on liver regeneration.

Palmes D, Zibert A, Budny T, Bahde R, Minin E, Kebschull L, Hölzen J, Schmidt H, Spiegel HU.

Virchows Arch. 2008 May;452(5):545-57. doi: 10.1007/s00428-008-0604-y.

PMID:
18398622
27.

[Liver-directed gene and cell therapy: future or present?].

Zibert A, Schmidt HH.

Z Gastroenterol. 2006 Nov;44(11):1177-9. Review. German. No abstract available.

PMID:
17115360
28.

Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.

Zibert A, Thomassen A, Müller L, Nguyen L, Glouchkova L, Fraefel C, Roskrow M, Meisel R, Dilloo D.

Gene Ther. 2005 Dec;12(23):1707-17.

PMID:
16034459
29.

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D.

Blood. 2004 Jun 15;103(12):4619-21. Epub 2004 Mar 4.

30.

CCL3/MIP-1alpha is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine.

Zibert A, Balzer S, Souquet M, Quang TH, Paris-Scholz C, Roskrow M, Dilloo D.

Hum Gene Ther. 2004 Jan;15(1):21-34.

PMID:
14965375
31.

Gene transfer for generation of tumor and leukemia vaccines.

Dilloo D, Zibert A.

Methods Mol Biol. 2003;215:261-77. No abstract available.

PMID:
12512305
32.

Transgenic IL-2 expression in Ewing tumor cell lines after transfection with Starburst dendrimers and cationic liposomes.

Ackermann B, Engel BC, Buttlies B, Zibert A, Burdach S.

Pediatr Hematol Oncol. 2002 Oct-Nov;19(7):509-20.

PMID:
12217197
33.

Tumor vaccines--application to childhood cancer.

Roskrow MA, Zibert A, Souquet M, Dilloo D.

Klin Padiatr. 1999 Jul-Aug;211(4):336-46. Review.

PMID:
10472573
34.

A suggested extension of the HCV ISDR does not alter our former conclusions on its predictive value for IFN response.

Rispeter K, Lu M, Zibert A, Wiese M, Mendes de Oliveira J, Roggendorf M.

J Hepatol. 1999 Jun;30(6):1163-4. No abstract available.

PMID:
10406200
35.

Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection.

Zibert A, Kraas W, Ross RS, Meisel H, Lechner S, Jung G, Roggendorf M.

J Hepatol. 1999 Feb;30(2):177-84.

PMID:
10068093
36.

The "interferon sensitivity determining region" of hepatitis C virus is a stable sequence element.

Rispeter K, Lu M, Zibert A, Wiese M, de Oliveira JM, Roggendorf M.

J Hepatol. 1998 Sep;29(3):352-61.

PMID:
9764980
37.

Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.

Lechner S, Rispeter K, Meisel H, Kraas W, Jung G, Roggendorf M, Zibert A.

Virology. 1998 Apr 10;243(2):313-21.

38.

Cloning and characterization of a complete open reading frame of the hepatitis C virus genome in only two cDNA fragments.

Rispeter K, Lu M, Lechner S, Zibert A, Roggendorf M.

J Gen Virol. 1997 Nov;78 ( Pt 11):2751-9.

PMID:
9367360
39.

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

Zibert A, Meisel H, Kraas W, Schulz A, Jung G, Roggendorf M.

Hepatology. 1997 May;25(5):1245-9.

PMID:
9141445
40.
42.
43.

The poliovirus receptor: identification of domains and amino acid residues critical for virus binding.

Bernhardt G, Harber J, Zibert A, deCrombrugghe M, Wimmer E.

Virology. 1994 Sep;203(2):344-56.

PMID:
7914388
44.

Typing of hepatitis C virus isolates by DNA enzyme immunoassay.

Viazov S, Zibert A, Ramakrishnan K, Widell A, Cavicchini A, Schreier E, Roggendorf M.

J Virol Methods. 1994 Jun;48(1):81-91.

PMID:
7962263
46.

The soluble form of two N-terminal domains of the poliovirus receptor is sufficient for blocking viral infection.

Zibert A, Selinka HC, Elroy-Stein O, Wimmer E.

Virus Res. 1992 Sep 1;25(1-2):51-61.

PMID:
1329376
47.
48.

Vaccinia virus-mediated expression and identification of the human poliovirus receptor.

Zibert A, Selinka HC, Elroy-Stein O, Moss B, Wimmer E.

Virology. 1991 May;182(1):250-9.

PMID:
1850905
49.

Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway.

Selinka HC, Zibert A, Wimmer E.

Proc Natl Acad Sci U S A. 1991 May 1;88(9):3598-602.

50.

Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA.

Zibert A, Maass G, Strebel K, Falk MM, Beck E.

J Virol. 1990 Jun;64(6):2467-73.

Supplemental Content

Loading ...
Support Center